Total Funding
31
1
Total FundingDebt Financing raised
Growth Score 31 in past quarter
-3 pts
Heat Score 1 in past quarter
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
720138
Metabolic Solutions Development develops innovative therapeutics based on a novel pharmacological method to treat type two diabetes.
Stephen C. Benoit: Board Member
Jerry Colca: Chief Scientific Officer, Co-Founder
About the Company
Metabolic Solutions Development Company is an emerging biopharmaceutical company developing first in class oral therapeutics to treat diseases associated with metabolic dysfunction, including NASH, polycystic kidney disease, and diabetes, as well as neurodegenerative diseases such as Alzheimer's and Parkinson's disease.

